Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $160K | $691K | $2.93M | $3.28M | $3.94M |
| Revenue growth | — | 331.9% | 323.7% | 11.9% | 20.4% |
| Gross profit | $105K | -$641K | $1.24M | $1.71M | $2.36M |
| Gross margin | 65.6% | -92.8% | 42.4% | 52.2% | 59.8% |
| Operating income | -$6.46M | -$18.7M | -$15.7M | -$13.8M | -$12.8M |
| Operating margin | -4038.1% | -2709.8% | -537.1% | -420.1% | -324.3% |
| Net income | -$7.05M | -$18.9M | -$15.6M | -$13.7M | -$12.6M |
| Net margin | -4405.0% | -2737.6% | -532.1% | -417.2% | -318.4% |
| EPS (diluted) | -$7.81 | -$23.62 | -$68.64 | -$11.26 | -$1.70 |
| Fiscal year | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Operating cash flow | -$4.29M | -$12.0M | -$12.2M | -$9.88M | -$10.7M |
| Capital expenditures | $102K | $847K | $361K | $186K | $273K |
| Free cash flow | -$4.39M | -$12.9M | -$12.5M | -$10.1M | -$11.0M |
| Fiscal year | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Cash & equivalents | $2.92M | $2.13M | $2.43M | $6.54M | $3.76M |
| Total assets | $9.27M | $11.1M | $6.34M | $9.84M | $10.8M |
| Total liabilities | $16.2M | $4.84M | $5.57M | $3.87M | $5.72M |
| Shareholders' equity | -$20.6M | $6.25M | $778K | $5.97M | $5.04M |
| Retained earnings | -$20.6M | -$39.5M | -$55.1M | -$68.7M | -$81.3M |
| Shares (wtd avg diluted) | 903M | 801M | 227M | 1.21B | 7.38B |
Every figure is extracted from Tenon Medical, Inc.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.